Detalhe da pesquisa
1.
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder.
Mov Disord
; 38(1): 57-67, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190111
2.
Binding of the Dual-Action Anti-Parkinsonian Drug AG-0029 to Dopamine D2 and Histamine H3 Receptors: A PET Study in Healthy Rats.
Mol Pharm
; 19(7): 2287-2298, 2022 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732005
3.
Head-to-head comparison of (R)-[11C]verapamil and [18F]MC225 in non-human primates, tracers for measuring P-glycoprotein function.
Eur J Nucl Med Mol Imaging
; 48(13): 4307-4317, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117508
4.
Pharmacokinetic Modeling of [18F]MC225 for Quantification of the P-Glycoprotein Function at the Blood-Brain Barrier in Non-Human Primates with PET.
Mol Pharm
; 17(9): 3477-3486, 2020 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32787277
5.
18F-FDG-PET uptake in non-infected total hip prostheses.
Acta Orthop
; 89(6): 634-639, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334468
6.
Evaluation of [(11)C]CB184 for imaging and quantification of TSPO overexpression in a rat model of herpes encephalitis.
Eur J Nucl Med Mol Imaging
; 42(7): 1106-18, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25771904
7.
[18 F]Fluoroethoxybenzovesamicol in Parkinson's disease patients: Quantification of a novel cholinergic positron emission tomography tracer.
Mov Disord
; 34(6): 924-926, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30977934
8.
Continuous ß-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity.
Neurology
; 103(1): e209419, 2024 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38862136
9.
Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure.
Ann Clin Transl Neurol
; 11(6): 1541-1556, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38757392
10.
Data sharing in neurodegenerative disease research: challenges and learnings from the innovative medicines initiative public-private partnership model.
Front Neurol
; 14: 1187095, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545729
11.
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study.
Alzheimers Res Ther
; 15(1): 189, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919783
12.
Mitigation of noise-induced bias of PET radiomic features.
PLoS One
; 17(8): e0272643, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006959
13.
Serotonergic system in vivo with [11C]DASB PET scans in GTP-cyclohydrolase deficient dopa-responsive dystonia patients.
Sci Rep
; 12(1): 6292, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428769
14.
Alzheimer's disease pattern derived from relative cerebral flow as an alternative for the metabolic pattern using SSM/PCA.
EJNMMI Res
; 12(1): 37, 2022 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737201
15.
Impact of cerebral blood flow and amyloid load on SUVR bias.
EJNMMI Res
; 12(1): 29, 2022 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35553267
16.
Regional associations of white matter hyperintensities and early cortical amyloid pathology.
Brain Commun
; 4(3): fcac150, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35783557
17.
The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact.
Front Neurol
; 13: 1063598, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36761917
18.
A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [18F]MK-6240.
EJNMMI Res
; 11(1): 49, 2021 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34046730
19.
Feasibility of pharmacokinetic parametric PET images in scaled subprofile modelling using principal component analysis.
Neuroimage Clin
; 30: 102625, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33756179
20.
Amyloid burden quantification depends on PET and MR image processing methodology.
PLoS One
; 16(3): e0248122, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33667281